title: Rituximab for severe mucous membrane pemphigoid: safe enough to be drug of first choice?
authors.forename: Michael
authors.initials: M
authors.lastname: Hertl
authors.forename: Philippe
authors.initials: P
authors.lastname: Bernard
authors.forename: Luca
authors.initials: L
authors.lastname: Borradori
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D001424:Bacterial Infections / Q000139:chemically induced / Q000276:immunology; D000075202:Contraindications; D006801:Humans; D010390:Pemphigoid, Benign Mucous Membrane / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D012720:Severity of Illness Index; D014777:Virus Diseases / Q000276:immunology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab